Clinical Summary Resources

Share

Program Content

Activities

  • Ab-Based Tx in B-cell Lymphomas
    Antibody-Based Therapies for B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2022

    Expires: April 27, 2023

  • BTKi for B-Cell Lymphomas
    BTK Inhibitors for B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2022

    Expires: April 27, 2023

  • Bispecific Antibodies in Indolent B-Cell Lymphomas
    Bispecific Antibodies in Indolent B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2022

    Expires: April 27, 2023

  • CAR T-cells for B-Cell Lymphomas
    CAR T-cell Therapy in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2022

    Expires: April 27, 2023

  • IMiDs in B-Cell Lymphomas
    Immunomodulatory Drugs (IMiDs) in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2022

    Expires: April 27, 2023

  • PI3Ki in Indolent B-Cell Lymphomas
    PI3K Inhibitors in Indolent B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2022

    Expires: April 27, 2023

  • Epigenetic therapy in Indolent B-Cell Lymphomas
    Epigenetic Therapy in Indolent B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2022

    Expires: April 27, 2023

Provided by

ProCE Banner

Supporters

Bayer Healthcare Pharma

Bristol Myers Squibb

Incyte Corporation